Dodson M G, Faro S
Rev Infect Dis. 1985 Nov-Dec;7 Suppl 4:S696-702. doi: 10.1093/clinids/7.supplement_4.s696.
Continued research on acute pelvic inflammatory disease (PID) has demonstrated that PID has a rather remarkably varied etiology, the pathogens responsible including Neisseria gonorrhoeae, Chlamydia trachomatis, aerobic and anaerobic gram-positive and gram-negative organisms, and possibly mycoplasmas. There is clearly no single antimicrobial agent that is effective against all of the organisms implicated in the etiology of acute PID. The aminoglycosides, generally in combination with an antibiotic such as clindamycin, are commonly used in the treatment of patients with acute PID. The combination of a new monocyclic beta-lactam antibiotic, aztreonam, and clindamycin may be less toxic and equally or more effective for the treatment of acute PID.
对急性盆腔炎(PID)的持续研究表明,PID的病因相当多样,致病病原体包括淋病奈瑟菌、沙眼衣原体、需氧和厌氧革兰氏阳性及革兰氏阴性菌,可能还有支原体。显然,没有一种单一的抗菌药物能有效对抗所有与急性PID病因相关的病原体。氨基糖苷类药物通常与克林霉素等抗生素联合使用,常用于治疗急性PID患者。新型单环β-内酰胺抗生素氨曲南与克林霉素联合使用可能毒性较小,对急性PID的治疗同样有效或更有效。